Oscient Pharmaceuticals Corp. has named Philippe M. Maitre as senior vice president and chief financial officer. As a senior executive with more than 25 years experience at several leading biotechnology, pharmaceutical and CROs, Mr. Maitre brings significant U.S. and global finance and business management expertise to the company. Mr. Maitre replaces Stephen Cohen, a 25-year veteran of Abbott Laboratories who is retiring after five years as chief financial officer at Oscient. Mr. Maitre has...